DRTS vs. QIPT, ARAY, CVRX, OBIO, CLPT, DCTH, PROF, TELA, KRMD, and BWAY
Should you be buying Alpha Tau Medical stock or one of its competitors? The main competitors of Alpha Tau Medical include Quipt Home Medical (QIPT), Accuray (ARAY), CVRx (CVRX), Orchestra BioMed (OBIO), ClearPoint Neuro (CLPT), Delcath Systems (DCTH), Profound Medical (PROF), TELA Bio (TELA), KORU Medical Systems (KRMD), and BrainsWay (BWAY). These companies are all part of the "surgical & medical instruments" industry.
Alpha Tau Medical (NASDAQ:DRTS) and Quipt Home Medical (NASDAQ:QIPT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, community ranking, dividends, profitability and media sentiment.
In the previous week, Alpha Tau Medical had 1 more articles in the media than Quipt Home Medical. MarketBeat recorded 5 mentions for Alpha Tau Medical and 4 mentions for Quipt Home Medical. Alpha Tau Medical's average media sentiment score of 0.89 beat Quipt Home Medical's score of -0.23 indicating that Alpha Tau Medical is being referred to more favorably in the media.
2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 42.9% of Quipt Home Medical shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 4.2% of Quipt Home Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Alpha Tau Medical has a net margin of 0.00% compared to Quipt Home Medical's net margin of -1.50%. Quipt Home Medical's return on equity of -3.57% beat Alpha Tau Medical's return on equity.
Alpha Tau Medical presently has a consensus price target of $12.00, indicating a potential upside of 349.44%. Quipt Home Medical has a consensus price target of $10.00, indicating a potential upside of 194.12%. Given Alpha Tau Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Alpha Tau Medical is more favorable than Quipt Home Medical.
Quipt Home Medical has higher revenue and earnings than Alpha Tau Medical. Quipt Home Medical is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.
Alpha Tau Medical has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500.
Quipt Home Medical received 12 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. Likewise, 82.76% of users gave Quipt Home Medical an outperform vote while only 60.00% of users gave Alpha Tau Medical an outperform vote.
Summary
Alpha Tau Medical beats Quipt Home Medical on 9 of the 17 factors compared between the two stocks.
Get Alpha Tau Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alpha Tau Medical Competitors List
Related Companies and Tools
